CD80 and neoplasm: In summary, the A20 leukemia transplantable cell line is a convenient tumor model for the assessment of the contribution of PD-L1 expression on hematopoietic tumor cells without the interference of CD80 co-expression, which permits the interplay of tumor PD-L1 with PD-1 expressed in immune cells to inhibit their function.